Burger - Figure 9
Diagnosis and treatment of non-muscle invasive bladder cancer: AUA / SUO Guideline
FIG. 9: The AUA)/American Society of Clinical Oncology (ASCO)/American Society for Radiation Oncology (ASTRO)/SUO guideline on treatment of non-metastatic muscle-invasive bladder cancer[4] describes every characteristic of urine histology as unique. The guideline acknowledges that no standard therapy or standard diagnostic workup has been defined, and that early systemic therapy should be considered.
References
Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: American Urological Association (AUA)/American Society of Clinical Oncology (ASCO)/American Society for Radiation Oncology (ASTRO)/Society of Urologic Oncology (SUO) guideline. Linthicum, MD: American Urological Association; 2017 http://www.auanet.org/documents/education/clinical-guidance/Muscle-Invasive-Bladder-Cancer.pdf Accessed August 11, 2017
